The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

3 results found.

Example of search result explained

Wezlana

Exceptional medication

Active ingredient(s):

ustekinumab (ulcerative colitis and Crohn's disease)
Manufactured by:

Amgen Canada Inc. (Amgen)
Strength and dosage form:
Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114312

Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114314

Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2544210

Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114313

Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 99114444

Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 99114443

Steqeyma

Exceptional medication

Active ingredient(s):

ustekinumab (ulcerative colitis and Crohn's disease)
Manufactured by:

Celltrion Healthcare Canada Limited (Celltrion)
Strength and dosage form:
Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114386

Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114387

Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2550261

Jamteki

Exceptional medication

Active ingredient(s):

ustekinumab (ulcerative colitis and Crohn's disease)
Manufactured by:

Jamp Pharma Corporation (Jamp)
Strength and dosage form:
Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114454

Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114456

Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2553120

Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114452

Wezlana

Steqeyma

Jamteki

How did we do?